Michael Doubek

36PUBLICATIONS
274CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 12, 2026
Comparable outcomes of BTK inhibitors and fixed-duration venetoclax plus rituximab in second-line treatment of chronic lymphocytic leukaemia: a real-world analysis by the Czech CLL study group.

|Aug 25, 2025
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial.

Thomas Chatzikonstantinou, Maria Vasilopoulou, Dimitrios Kyrou

|Aug 21, 2025
Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation.

Veronika Zimolova, Monika Burocziova, Linda Berkova

|Jun 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Ferran Nadeu, Shimin Shuai, Guillem Clot

|Jan 22, 2025
Detection of clinically relevant variants in the <i>TP53</i> gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|Jan 15, 2025
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.

Axel Rüfer, Henning Nilius, Olivier Hermine

Pageof 6

Frequent Collaborators

12 joint publications

Šárka Pospíšilová

6 joint publications

Karla Plevova

6 joint publications

Paolo Ghia

5 joint publications

Jiri Mayer